Cite
COVID-19 and emerging viral infections: The case for interferon lambda
MLA
Prokunina-Olsson, Ludmila, et al. “COVID-19 and Emerging Viral Infections: The Case for Interferon Lambda.” The Journal of Experimental Medicine, vol. 217, no. 5, May 2020, p. e20200653. EBSCOhost, https://doi.org/10.1084/jem.20200653.
APA
Prokunina-Olsson, L., Alphonse, N., Dickenson, R. E., Durbin, J. E., Glenn, J. S., Hartmann, R., Kotenko, S. V., Lazear, H. M., O, B. T. R., Odendall, C., Onabajo, O. O., Piontkivska, H., Santer, D. M., Reich, N. C., Wack, A., & Zanoni, I. (2020). COVID-19 and emerging viral infections: The case for interferon lambda. The Journal of Experimental Medicine, 217(5), e20200653. https://doi.org/10.1084/jem.20200653
Chicago
Prokunina-Olsson, Ludmila, Noémie Alphonse, Ruth E. Dickenson, Joan E. Durbin, Jeffrey S. Glenn, Rune Hartmann, Sergei V. Kotenko, et al. 2020. “COVID-19 and Emerging Viral Infections: The Case for Interferon Lambda.” The Journal of Experimental Medicine 217 (5): e20200653. doi:10.1084/jem.20200653.